Furthermore, EVA1C was considered as a risk factor for glioma patients as Kaplan-Meier curves showed that the high EVA1C expression group presented poorer prognosis than the low expression group (Figure 2C). This evidence concerns the gene EVA1C and central nervous system cancer.